These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 9270019

  • 1. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
    Cuthbert JA, Lipsky PE.
    Cancer Res; 1997 Aug 15; 57(16):3498-505. PubMed ID: 9270019
    [Abstract] [Full Text] [Related]

  • 2. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
    Cuthbert JA, Lipsky PE.
    Cancer Res; 1995 Apr 15; 55(8):1732-40. PubMed ID: 7712482
    [Abstract] [Full Text] [Related]

  • 3. Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates.
    Cuthbert JA, Lipsky PE.
    J Biol Chem; 1991 Sep 25; 266(27):17966-71. PubMed ID: 1917936
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.
    Cuthbert JA, Lipsky PE.
    J Biol Chem; 1990 Oct 25; 265(30):18568-75. PubMed ID: 2211719
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC.
    Anticancer Res; 2000 Oct 25; 20(4):2761-71. PubMed ID: 10953355
    [Abstract] [Full Text] [Related]

  • 6. Requirement for mevalonate in the control of proliferation of human breast cancer cells.
    Wejde J, Blegen H, Larsson O.
    Anticancer Res; 1992 Oct 25; 12(2):317-24. PubMed ID: 1580550
    [Abstract] [Full Text] [Related]

  • 7. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ.
    Clin Cancer Res; 2001 Jan 25; 7(1):158-67. PubMed ID: 11205904
    [Abstract] [Full Text] [Related]

  • 8. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW, Jung SE.
    J Pharmacol Exp Ther; 1999 Apr 25; 289(1):572-9. PubMed ID: 10087052
    [Abstract] [Full Text] [Related]

  • 9. Lovastatin inhibits proliferation of rat mesangial cells.
    O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF.
    J Clin Invest; 1993 Jan 25; 91(1):83-7. PubMed ID: 8423236
    [Abstract] [Full Text] [Related]

  • 10. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB, Silverman KC, Jayasuriya H, Kim BM, Amo SE, Wilson FR, Rew DJ, Schaber MD, Bergstrom JD, Koblan KS, Graham SL, Kohl NE, Gibbs JB, Singh SB.
    J Med Chem; 1998 Nov 05; 41(23):4492-501. PubMed ID: 9804689
    [Abstract] [Full Text] [Related]

  • 11. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.
    Exp Biol Med (Maywood); 2007 Apr 05; 232(4):523-31. PubMed ID: 17392488
    [Abstract] [Full Text] [Related]

  • 12. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ.
    Exp Eye Res; 1997 Jul 05; 65(1):63-72. PubMed ID: 9237866
    [Abstract] [Full Text] [Related]

  • 13. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
    Wang M, Xie Y, Girnita L, Nilsson G, Dricu A, Wejde J, Larsson O.
    Exp Cell Res; 1999 Jan 10; 246(1):38-46. PubMed ID: 9882513
    [Abstract] [Full Text] [Related]

  • 14. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
    O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF.
    Miner Electrolyte Metab; 1993 Jan 10; 19(3):173-9. PubMed ID: 8232104
    [Abstract] [Full Text] [Related]

  • 15. Requirement for mevalonate in cycling cells: quantitative and temporal aspects.
    Doyle JW, Kandutsch AA.
    J Cell Physiol; 1988 Oct 10; 137(1):133-40. PubMed ID: 3170653
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
    Maltese WA, Sheridan KM.
    J Cell Physiol; 1985 Dec 10; 125(3):540-58. PubMed ID: 3851809
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.